# Kedplasma LLC – FDA Inspection, Jan 26, 2023

Source: https://www.keypedia.com/records/fda_inspections/kedplasma-llc/cf630437-04ce-400b-b4a7-39f2a6182dd9
Source feed: FDA_Inspections

> FDA inspection 1196531 of Kedplasma LLC, January 26, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 630. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1196531
- Company Name: Kedplasma LLC
- Inspection Date: 2023-01-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1114126 - 2019-12-11
- FDA Inspection 1085589 - 2019-03-29
- FDA Inspection 1022662 - 2017-07-28

## Related Officers

- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)

Company: https://www.keypedia.com/companies/kedplasma-llc/3f3aacfd-d14e-4ef0-9b1e-fd0853808e6a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
